Celldex Therapeutics
Patents, Design & Utilities
Last updated:
List of all Celldex Therapeutics patents 30 in total
| Status | Patent |
|---|---|
Application | Utility: ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: ANTI-AXL ANTIBODIES AND METHODS OF USE THEREOF Filling date: 8 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: TREATMENT OF EOSINOPHIL OR MAST CELL RELATED DISORDERS Filling date: 8 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS Filling date: 8 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: ANTI-KIT ANTIBODIES AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Utility: Antibodies that bind human CD27 and uses thereof Filling date: 8 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Anti-ALK antibodies and methods for use thereof Filling date: 8 Sep 2025 Issue date: 17 Aug 2021 |
Application | Utility: ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS Filling date: 8 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: AGONISTIC ANTIBODIES THAT BIND CD40 Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Anti-MET Antibodies and Methods of Use Thereof Filling date: 8 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH DENDRITIC CELL MOBILIZING AGENTS Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies Filling date: 8 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Nucleic acids encoding agonistic antibodies that bind CD40 Filling date: 8 Sep 2025 Issue date: 15 Dec 2020 |
Application | Utility: ANTI-KIT ANTIBODIES AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 26 Nov 2020 |
Grant | Utility: Methods of treating by administering anti-kit antibodies Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Methods of treating by administering anti-kit antibodies Filling date: 8 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Treatment of eosinophil or mast cell related disorders Filling date: 8 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Anti-ErbB antibodies and methods of use thereof Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment Filling date: 8 Sep 2025 Issue date: 2 Jun 2020 |
Application | Utility: Anti-ALK Antibodies and Methods for Use Thereof Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: Agonistic antibodies that bind CD40 Filling date: 8 Sep 2025 Issue date: 28 Apr 2020 |
Application | Utility: ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS Filling date: 8 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: VACCINE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: CHIMERIC ANTIGEN RECEPTORS TARGETING TIM-1 Filling date: 8 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment Filling date: 8 Sep 2025 Issue date: 27 Aug 2019 |
Showing 1 to 30 of 30 patents.